Invests in
Locations:
Min Investment:
$50,000.00Max Investment:
$150,000,000.00Target Investment:
$25,000,000.00
Skills
Education
Lists including Reetika
Work Experience
2019
Senior Associate
2019
Associate 2020-2022 Senior Associate 2023-now - Dedicated to company building and direct investing into disruptive life sciences companies across indications, technologies, and modalities -Source and evaluate investment opportunities across biotech and life sciences that have signifcant impact on human health -Create new ventures and operate within portfolio companies. Investments: Pretzel, AIRNA, Moleculent, Protillion, Metsera, KoreAx, Cytrellis Operations: Walden, Tenvie, Cytrellis, Pretzel
2021
Board Observer
2021
-Investment and company formation of Pretzel -Business development, Competitive intelligence
2022
Board Observer
2022
-Direct Investment, syndicate formation -Business development, strategy, operations, competitive intelligence, and chief of staff duties for early stage RNA editing company, from seed through Series B -Indication selection, TPP
2024
Board Observer
2024
- Direct investment - Portfolio support
2023
Board Observer
2023
Board Member
2021
- Investor relations -Commercial operations and strategy
Innovation Fund Associate
2019 - 2020
• Perform due diligence on a Sleep disorder therapeutics and a pediatric insomnia device company; analyzing potential market, reviewing technology, and assessing development milestone • Advised advisory committee to invest $250K per startup from a $20 M seed fund ; the companies were successfully funded • Served in a venture capital associate role in order to equip the Shultz Innovation Fund Advisory Committee to make investment decisions
2019 - 2019
Investment Banking Associate (M&A)
2019 - 2019
2018 - 2019
I-Corp Fellow
2018 - 2019
Business Development Lead for early stage startups in the field of Neuroscience- Alzheimer and Sleep Apnea
2015 - 2018
Scientific Advisor and Business Development
2015 - 2018